Diabetes, Vol 48, Issue 8 1652-1657, Copyright © 1999 by American Diabetes Association

ARTICLES

Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene

B Glaser, F Ryan, M Donath, H Landau, CA Stanley, L Baker, DE Barton and PS Thornton
Department of Endocrinology and Metabolism, Hebrew University, Hadassah Medical School, Jerusalem, Israel. beng@cc.huji.ac.il

Neonatal hyperinsulinism (HI) is a genetic disorder of pancreatic beta-cells characterized by failure to suppress insulin secretion in the presence of hypoglycemia, resulting in brain damage or death if not adequately treated. Germline mutations in four genes have been associated with HI. Some patients have focal regions of beta-cell proliferation (focal HI). Seventy HI probands in whom at least one SUR-1 mutation was identified were studied. Clinical data from patients with two SUR-1 mutant alleles were compared with those from patients with single paternally inherited mutations. Thirty-seven probands were homozygous or compound heterozygous for SUR-1 mutations. In 33 probands, only a single mutation was identified, and in 31, the parental origin of the proband could be determined; in 29, the mutation was on the paternal allele (P < 0.0002). For three of these, pancreatic tissue was available and showed focal beta-cell hyperplasia. DNA extracted from the focal lesion and adjacent normal pancreas revealed loss of the maternal chromosome 11p15, resulting in reduction to homozygosity for the SUR-1 mutation within the focal lesion only. Using the Tdt-mediated dUTP nick end labeling (TUNEL) reaction, apoptotic beta-cells were identified exclusively within the focal region. At diagnosis, disease severity was similar in patients with paternally inherited mutations and those with two mutations. For patients who did not undergo surgery, those with only paternal mutations entered clinical remission within 16 +/- 6.2 months, compared with 48 +/- 23 months for those with two SUR-1 mutations (P = 0.001). In conclusion, we identified a novel mechanism to explain the pathophysiology of focal HI and provide evidence to suggest that this entity may be self-limiting, since affected beta-cells undergo apoptosis.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Abdulhadi-Atwan, J. D. Bushman, S. Tornovsky-Babaey, A. Perry, A. Abu-Libdeh, B. Glaser, S.-L. Shyng, and D. H. Zangen Novel De Novo Mutation in Sulfonylurea Receptor 1 Presenting as Hyperinsulinism in Infancy Followed by Overt Diabetes in Early Adolescence Diabetes, July 1, 2008; 57(7): 1935 - 1940. [Abstract] [Full Text] [PDF]

				E. Marthinet, A. Bloc, Y. Oka, Y. Tanizawa, B. Wehrle-Haller, V. Bancila, J.-M. Dubuis, J. Philippe, and V. M. Schwitzgebel Severe Congenital Hyperinsulinism Caused by a Mutation in the Kir6.2 Subunit of the Adenosine Triphosphate-Sensitive Potassium Channel Impairing Trafficking and Function J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5401 - 5406. [Abstract] [Full Text] [PDF]

				F. Ashcroft and P. Rorsman Type 2 diabetes mellitus: not quite exciting enough? Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R21 - R31. [Abstract] [Full Text] [PDF]

				C. A. Stanley, P. S. Thornton, A. Ganguly, C. MacMullen, P. Underwood, P. Bhatia, L. Steinkrauss, L. Wanner, R. Kaye, E. Ruchelli, et al. Preoperative Evaluation of Infants with Focal or Diffuse Congenital Hyperinsulinism by Intravenous Acute Insulin Response Tests and Selective Pancreatic Arterial Calcium Stimulation J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 288 - 296. [Abstract] [Full Text] [PDF]

				M. J. DUNNE, K. E. COSGROVE, R. M. SHEPHERD, A. AYNSLEY-GREEN, and K. J. LINDLEY Hyperinsulinism in Infancy: From Basic Science to Clinical Disease Physiol Rev, January 1, 2004; 84(1): 239 - 275. [Abstract] [Full Text] [PDF]

				P. S. Thornton, C. MacMullen, A. Ganguly, E. Ruchelli, L. Steinkrauss, A. Crane, L. Aguilar-Bryan, and C. A. Stanley Clinical and Molecular Characterization of a Dominant Form of Congenital Hyperinsulinism Caused by a Mutation in the High-Affinity Sulfonylurea Receptor Diabetes, September 1, 2003; 52(9): 2403 - 2410. [Abstract] [Full Text] [PDF]

				C. A. Stanley Advances in Diagnosis and Treatment of Hyperinsulinism in Infants and Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4857 - 4859. [Full Text] [PDF]

				H. Huopio, J. Jaaskelainen, J. Komulainen, R. Miettinen, P. Karkkainen, M. Laakso, P. Tapanainen, R. Voutilainen, and T. Otonkoski Acute Insulin Response Tests for the Differential Diagnosis of Congenital Hyperinsulinism J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4502 - 4507. [Abstract] [Full Text] [PDF]

				H. Huopio, S.-L. Shyng, T. Otonkoski, and C. G. Nichols KATP channels and insulin secretion disorders Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E207 - E216. [Abstract] [Full Text] [PDF]

				H. Huopio, I. Vauhkonen, J. Komulainen, L. Niskanen, T. Otonkoski, and M. Laakso Carriers of an Inactivating {beta}-Cell ATP-Sensitive K+ Channel Mutation Have Normal Glucose Tolerance and Insulin Sensitivity and Appropriate Insulin Secretion Diabetes Care, January 1, 2002; 25(1): 101 - 106. [Abstract] [Full Text] [PDF]

				A. Sadeghi-Nejad and F. M. Graeme-Cook Case 39-2001- A Newborn Girl with Seizures and Persistent Hypoglycemia N. Engl. J. Med., December 20, 2001; 345(25): 1833 - 1839. [Full Text] [PDF]

				J.-C. Fournet, C. Mayaud, P. de Lonlay, M.-S. Gross-Morand, V. Verkarre, M. Castanet, M. Devillers, J. Rahier, F. Brunelle, J.-J. Robert, et al. Unbalanced Expression of 11p15 Imprinted Genes in Focal Forms of Congenital Hyperinsulinism : Association with a Reduction to Homozygosity of a Mutation in ABCC8 or KCNJ11 Am. J. Pathol., June 1, 2001; 158(6): 2177 - 2184. [Abstract] [Full Text] [PDF]

				A. Grimberg, R.J. Ferry Jr., A. Kelly, S. Koo-McCoy, K. Polonsky, B. Glaser, M.A. Permutt, L. Aguilar-Bryan, D. Stafford, P.S. Thornton, et al. Dysregulation of Insulin Secretion in Children With Congenital Hyperinsulinism due to Sulfonylurea Receptor Mutations Diabetes, February 1, 2001; 50(2): 322 - 328. [Abstract] [Full Text]

				P. M. Thomas Neonatal Insulin Secretion and Persistent Hyperinsulinemia of Infancy NeoReviews, November 1, 2000; 1(11): e210 - 214. [Full Text]

				B. Glaser, P. Thornton, T. Otonkoski, and C. Junien Genetics of neonatal hyperinsulinism Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2000; 82(2): 79F - 86. [Abstract] [Full Text]